Anne L. Hansen
Aarhus C, 8000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 16, 2026
NRF2 controls a diverse network of antiviral effectors with p62 acting as a central restriction factor effective across virus families.
Journal: Redox biology
Published: March 04, 2026
Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2.
Journal: Nature communications
Published: July 08, 2025
Development of nitroalkene-based inhibitors to target STING-dependent inflammation.
Journal: Redox biology
Published: April 18, 2024
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.
Journal: ACS infectious diseases
Published: October 18, 2021
Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium.
Journal: iScience
Published: June 30, 2021
Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis.
Journal: BMC immunology
Published: March 22, 2021
Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis.
Journal: Clinical and experimental gastroenterology
Published: January 26, 2021
Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate.
Journal: Nature communications
Published: October 22, 2020
Last Updated: 09/26/2026